Risiko von Zweitmalignomen nach platinbasierter Chemotherapie von Hodentumoren
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Link
http://link.springer.com/article/10.1007/s00066-018-1410-3/fulltext.html
Reference11 articles.
1. Thomas G, Sturgeon J, Alison R, Jewett M, Goldberg S, Sugar L et al (1989) A study of post-orchiectomy surveillance in stage I testicular seminoma. J Urol 142(2):313–316
2. Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R et al (2011) Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29(8):957–962
3. Tandstad T, Ståhl O, Dahl O, Haugnes H, Håkansson U, Karlsdottir Å et al (2016) Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Ann Oncol 27(7):1299–1304
4. Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A et al (2011) Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. J Clin Oncol 29(6):719–725
5. van de Wetering RA, Sleijfer S, Feldman DR, Funt SA, Bosl GJ, de Wit R (2018) Controversies in the management of clinical stage I seminoma: carboplatin a decade in-time to start backing out. J Clin Oncol 36(9):837
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multimodale Therapie des Hodentumors: wann Chemotherapie, Operation oder Strahlentherapie?;Die Urologie;2022-10-12
2. Therapiemöglichkeiten des Seminoms im klinischen Stadium I und II unter Berücksichtigung der Langzeittoxizität;Der Onkologe;2020-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3